SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff

Intel VP: “We had 11 or 12 layers of management... now it’s 5 or 6”

From textile recycling to autonomous vessels: The vision behind the Dream Team startups

ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”

Buzz

Most popular

Daily

Weekly

1

Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing

2

Check Point raises $1.75 billion, potentially eyeing AI expansion

3

Hapag-Lloyd eyes ZIM acquisition, workers push back

4

Sequoia’s Shaun Maguire says Israel risks losing “a war it can’t see”

5

Cybereason founders' 7AI raises record $130 million Series A in breakneck rise

Richard Francis

3 stories about Richard Francis

מטה טבע כפר סבא

Teva surpasses expectations in Q4 but sets cautious outlook for 2025

29.01.25|Sophie Shulman

Despite a strong finish to the year, Teva forecasts lower-than-expected earnings and revenue growth for 2025.

ריצרד פרנסיס נשיא ו מנכל חברה חברת טב

Teva soars with double-digit growth in Q3, raises annual forecast

06.11.24|Sophie Shulman

Strong sales of Austedo and Ajovy push Teva’s revenues above expectations, with the company forecasting up to $16.5 billion in 2024.

מפגש עיתונאים ראשון עם נשיא ומנכל חברת טבע ריצ'רד פרנסיס

Teva CEO: "The company played not to lose, now we’ll play to win"

21.02.24|Sophie Shulman

Richard Francis' decision to focus on innovative drugs has boosted the stock by 40% since he took office. However, the high debt is still burdensome and the realization of the potential depends on the success of developments that are still in the laboratory